{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:01:29Z","timestamp":1746417689894,"version":"3.40.4"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital","award":["CY2019-BJ07"],"award-info":[{"award-number":["CY2019-BJ07"]}]},{"DOI":"10.13039\/501100004775","name":"Gansu Natural Science Foundation","doi-asserted-by":"crossref","award":["20JR10RA745"],"award-info":[{"award-number":["20JR10RA745"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gansu Province College Students Innovation and Entrepreneurship Training Plan Project","award":["202111805003"],"award-info":[{"award-number":["202111805003"]}]},{"name":"Key Research Project of Pingliang Science and Technology","award":["PL-STK-2021A-004"],"award-info":[{"award-number":["PL-STK-2021A-004"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Coronavirus disease 2019, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread worldwide, resulting in over 250 million infections and &gt;5 million deaths. Most antiviral drugs and vaccines have shown limited efficacy against SARS-CoV-2. Clinical data revealed that except for the large number of self-healing mild cases, moderate and severe cases mostly survived after supportive treatment but not specific drug administration or vaccination. The endothelial system is the first physiological barrier, and its structural stability is of critical importance in conferring disease resistance. Membrane lipid components, particularly sphingosine-1-phosphate (S1P), play a central role in stabilizing the cell membrane.<\/jats:p>\n            <jats:p>Here, we used \u201cBoolean Operators\u201d such as AND, OR, and NOT, to search for relevant research articles in PubMed, then reviewed the potential of S1P in inhibiting SARS-CoV-2 infection by stabilizing the endothelial system, this is the major aim of this review work.<\/jats:p>\n            <jats:p>Reportedly, vasculitis and systemic inflammatory vascular diseases are caused by endothelial damage resulting from SARS-CoV-2 infection. S1P, S1P receptor (SIPR), and signaling were involved in the process of SARS-CoV-2 infection, and S1P potentially regulated the function of EC barrier, in turn, inhibited the SARS-CoV-2 to infect the endothelial cells, and ultimately has the promising therapeutic value to coronavirus disease 2019.<\/jats:p>\n            <jats:p>Taken together, we conclude that maintaining or administering a high level of S1P will preserve the integrity of the EC structure and function, in turn, lowering the risk of SARS-CoV-2 infection and reducing complications and mortality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029164","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T14:35:31Z","timestamp":1651070131000},"page":"e29164","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Potential of sphingosine-1-phosphate in preventing SARS-CoV-2 infection by stabilizing and protecting endothelial cells"],"prefix":"10.1097","volume":"101","author":[{"given":"Rongzhi","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Gansu Medical College, Pingliang, Gansu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7069-6072","authenticated-orcid":false,"given":"Jianshe","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Lanzhou University Second Hospital, Lanzhou, Gansu, China"},{"name":"Gansu Medical College, Pingliang, Gansu, China"},{"name":"Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.prostaglandins.2005.06.008","article-title":"Genomic insights into mediator lipidomics","volume":"77","author":"Hla","year":"2005","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12964-020-00543-8","article-title":"Biology of phosphatidylserine (PS): basic physiology and implications in immunology, infectious disease, and cancer","volume":"18","author":"Calianese","year":"2020","journal-title":"Cell Commun Signal"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40265-016-0603-2","article-title":"Sphingosine-1-phosphate (S1P) and S1P signaling pathway: therapeutic targets in autoimmunity and inflammation","volume":"76","author":"Tsai","year":"2016","journal-title":"Drugs"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI76369","article-title":"Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy","volume":"125","author":"Proia","year":"2015","journal-title":"J Clin Invest"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.011008.145616","article-title":"Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation","volume":"49","author":"Shimizu","year":"2009","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1515\/bchm2.1968.349.2.1745","article-title":"Metabolism of sphingosine bases. IX. Degradation in vitro of dihydrospingosine and dihydrospingosine phosphate to palmitaldehyde and ethanolamine phosphate","volume":"349","author":"Stoffel","year":"1968","journal-title":"Hoppe Seylers Z Physiol Chem"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.2163543","article-title":"Intracellular calcium release mediated by sphingosine derivatives generated in cells","volume":"248","author":"Ghosh","year":"1990","journal-title":"Science"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1083\/jcb.114.1.155","article-title":"Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation","volume":"114","author":"Zhang","year":"1991","journal-title":"J Cell Biol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1124\/pr.110.003111","article-title":"International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature","volume":"62","author":"Chun","year":"2010","journal-title":"Pharmacol Rev"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nature09128","article-title":"Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2","volume":"465","author":"Alvarez","year":"2010","journal-title":"Nature"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1176709","article-title":"Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate","volume":"325","author":"Hait","year":"2009","journal-title":"Science"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1096\/fj.10-167502","article-title":"Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration","volume":"25","author":"Strub","year":"2011","journal-title":"FASEB J"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"eaat6662","DOI":"10.1126\/scisignal.aat6662","article-title":"Activation of atypical protein kinase C by sphingosine 1-phosphate revealed by an aPKC-specific activity reporter","volume":"12","author":"Kajimoto","year":"2019","journal-title":"Sci Signal"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"ra58","DOI":"10.1126\/scisignal.aaa4998","article-title":"Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation","volume":"8","author":"Panneer Selvam","year":"2015","journal-title":"Sci Signal"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e10592","DOI":"10.7554\/eLife.10592","article-title":"TRAF2 regulates TNF and NF-\u03baB signalling to suppress apoptosis and skin inflammation independently of sphingosine kinase 1","volume":"4","author":"Etemadi","year":"2015","journal-title":"eLife"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/dvdy.24288","article-title":"Maternal or zygotic sphingosine kinase is required to regulate zebrafish cardiogenesis","volume":"244","author":"Mendelson","year":"2015","journal-title":"Dev Dyn"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"e21992","DOI":"10.7554\/eLife.21992","article-title":"The ceramide synthase 2b gene mediates genomic sensing and regulation of sphingosine levels during zebrafish embryogenesis","volume":"6","author":"Mendelson","year":"2017","journal-title":"eLife"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"32563","DOI":"10.1074\/jbc.M113.483750","article-title":"Sphingosine kinases are not required for inflammatory responses in macrophages","volume":"288","author":"Xiong","year":"2013","journal-title":"J Biol Chem"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1042\/bj3520809","article-title":"Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions","volume":"352","author":"Murata","year":"2000","journal-title":"Biochem J"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.1113640","article-title":"Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients","volume":"309","author":"Schwab","year":"2005","journal-title":"Science"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-physiol-021014-071635","article-title":"Vascular and immunobiology of the circulatory sphingosine 1-phosphate gradient","volume":"79","author":"Yanagida","year":"2017","journal-title":"Annu Rev Physiol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1172\/JCI89626","article-title":"Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency","volume":"127","author":"Lovric","year":"2017","journal-title":"J Clin Invest"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ajhg.2015.12.004","article-title":"Autosomal-recessive hearing impairment due to rare missense variants within S1PR2","volume":"98","author":"Santos-Cortez","year":"2016","journal-title":"Am J Hum Genet"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"e753","DOI":"10.1212\/NXI.0000000000000753","article-title":"COVID-19 infection in a patient with multiple sclerosis treated with fingolimod","volume":"7","author":"Barzegar","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"114296","DOI":"10.1016\/j.bcp.2020.114296","article-title":"Repurposing existing drugs for the treatment of COVID-19\/SARS-CoV-2 infection: a review describing drug mechanisms of action","volume":"183","author":"Yousefi","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.7861\/clinmed.2020-0309","article-title":"Rationale for the use of sphingosine analogues in COVID-19 patients","volume":"21","author":"Tasat","year":"2021","journal-title":"Clin Med (Lond)"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"102437","DOI":"10.1016\/j.msard.2020.102437","article-title":"The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients","volume":"45","author":"Kloc","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/jmv.26279","article-title":"Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal","volume":"93","author":"Gomez-Mayordomo","year":"2021","journal-title":"J Med Virol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.3390\/ijms21186773","article-title":"SARS-CoV-2 infection: a role for S1P\/S1P receptor signaling in the nervous system?","volume":"21","author":"Meacci","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1007\/s00415-021-10556-z","article-title":"Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?","volume":"268","author":"Orrico","year":"2021","journal-title":"J Neurol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"271.e8","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"22894","DOI":"10.1074\/jbc.M116.756114","article-title":"Calcium signaling is dispensable for receptor regulation of endothelial barrier function","volume":"291","author":"Stolwijk","year":"2016","journal-title":"J Biol Chem"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1537-1891(03)00007-7","article-title":"Role of Ca2+ signaling in the regulation of endothelial permeability","volume":"39","author":"Tiruppathi","year":"2002","journal-title":"Vasc Pharmacol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/jmr.953","article-title":"Effect of thrombin and bradykinin on endothelial cell mechanical properties monitored through membrane deformation","volume":"22","author":"Cuerrier","year":"2009","journal-title":"J Mol Recognit"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"37118","DOI":"10.1074\/jbc.M502207200","article-title":"SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism","volume":"280","author":"Maceyka","year":"2005","journal-title":"J Biol Chem"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/BJ20060251","article-title":"Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient","volume":"397","author":"Venkataraman","year":"2006","journal-title":"Biochem J"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"14196","DOI":"10.1073\/pnas.95.24.14196","article-title":"Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway","volume":"95","author":"Xia","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"27667","DOI":"10.1074\/jbc.M113.489443","article-title":"Sphingosine kinase 1 regulates tumor necrosis factor-mediated RANTES induction through p38 mitogen-activated protein kinase but independently of nuclear factor \u03baB activation","volume":"288","author":"Adada","year":"2013","journal-title":"J Biol Chem"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/cells9071652","article-title":"COVID-19, renin-angiotensin system and endothelial dysfunction","volume":"9","author":"Amraei","year":"2020","journal-title":"Cells"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"905.e7","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccc.2019.12.001","article-title":"Immune consequences of endothelial cells\u2019 activation and dysfunction during sepsis","volume":"36","author":"Pons","year":"2020","journal-title":"Crit Care Clin"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","article-title":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia","volume":"2","author":"McGonagle","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/s41467-020-16048-4","article-title":"Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig","volume":"11","author":"Lei","year":"2020","journal-title":"Nat Commun"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3727\/096368914X685087","article-title":"Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury","volume":"24","author":"He","year":"2015","journal-title":"Cell Transplant"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.it.2020.09.004","article-title":"Structural basis of SARS-CoV-2 and SARS-CoV antibody interactions","volume":"41","author":"Gavor","year":"2020","journal-title":"Trends Immunol"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"110320","DOI":"10.1016\/j.mehy.2020.110320","article-title":"SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients","volume":"145","author":"Kumar","year":"2020","journal-title":"Med Hypotheses"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","article-title":"Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China","volume":"98","author":"Su","year":"2020","journal-title":"Kidney Int"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s00134-020-06057-8","article-title":"Lille COVID-19 ICU and Anatomopathology Group. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection","volume":"46","author":"Copin","year":"2020","journal-title":"Intensive Care Med"},{"key":"R56-20250504","first-page":"217","article-title":"Clinical pathology and pathogenesis of severe acute respiratory syndrome","volume":"17","author":"Zhao","year":"2003","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/path.1560","article-title":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways","volume":"203","author":"Ding","year":"2004","journal-title":"J Pathol"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/426870","article-title":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus","volume":"191","author":"Farcas","year":"2005","journal-title":"J Infect Dis"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"R61-20250504","doi-asserted-by":"crossref","first-page":"14043","DOI":"10.1128\/JVI.78.24.14043-14047.2004","article-title":"Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway","volume":"78","author":"Tan","year":"2004","journal-title":"J Virol"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/v12010014","article-title":"Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?","volume":"12","author":"Desforges","year":"2019","journal-title":"Viruses"},{"key":"R63-20250504","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1164\/rccm.201305-0954LE","article-title":"Emerging human middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs","volume":"188","author":"Hocke","year":"2013","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:07:23Z","timestamp":1746328043000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029164"}},"subtitle":["Narrative review"],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":63,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029164","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"assertion":[{"value":"2021-11-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}